OHR PHARMACEUTICAL INC's ticker is OHRP and the CUSIP is 67778H200. A total of 43 filers reported holding OHR PHARMACEUTICAL INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $0 | – | 21 | 0.0% | 0.00% | – |
Q2 2018 | $0 | – | 21 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 21 | 0.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 21 | -99.9% | 0.00% | – |
Q3 2017 | $14,000 | +7.7% | 20,021 | 0.0% | 0.00% | – |
Q2 2017 | $13,000 | -23.5% | 20,021 | 0.0% | 0.00% | – |
Q1 2017 | $17,000 | -43.3% | 20,021 | 0.0% | 0.00% | – |
Q4 2016 | $30,000 | -78.1% | 20,021 | -58.7% | 0.00% | – |
Q3 2016 | $137,000 | -2.8% | 48,521 | -5.8% | 0.00% | – |
Q2 2016 | $141,000 | -63.6% | 51,521 | -57.3% | 0.00% | – |
Q1 2016 | $387,000 | -47.7% | 120,521 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $740,000 | +150.0% | 120,521 | +12.1% | 0.00% | – |
Q3 2015 | $296,000 | +70.1% | 107,521 | +55.8% | 0.00% | – |
Q2 2015 | $174,000 | -1.1% | 69,021 | 0.0% | 0.00% | – |
Q1 2015 | $176,000 | -69.4% | 69,021 | 0.0% | 0.00% | -100.0% |
Q4 2014 | $576,000 | +2.1% | 69,021 | -11.4% | 0.00% | 0.0% |
Q3 2014 | $564,000 | -14.0% | 77,866 | +12.8% | 0.00% | 0.0% |
Q2 2014 | $656,000 | +39.6% | 69,000 | +100.0% | 0.00% | 0.0% |
Q1 2014 | $470,000 | – | 34,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GARRISON BRADFORD & ASSOCIATES INC | 85,415 | $55,000 | 0.05% |
Leisure Capital Management | 65,199 | $42,000 | 0.04% |
SABBY MANAGEMENT, LLC | 681,300 | $436,000 | 0.03% |
Cutter & CO Brokerage, Inc. | 44,975 | $29,000 | 0.01% |
SALZHAUER MICHAEL | 35,715 | $23,000 | 0.01% |
Cannell & Co. | 292,858 | $187,000 | 0.01% |
Tower Research Capital LLC (TRC) | 70,933 | $45,000 | 0.01% |
JT Stratford LLC | 10,000 | $6,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 15,086 | $10,000 | 0.00% |
STONERIDGE INVESTMENT PARTNERS LLC | 14,952 | $10,000 | 0.00% |